Media: Chinese biotech I-Mab weighing options including sale - Bloomberg News
20/04/2022 13:05
-- Source link: https://bloom.bg/3uYSIm0
-- Note: Reuters has not verified this story and does not
vouch for its accuracy
((Bengaluru newsroom, globalnewsmonitoring@thomsonreuters.com))
Recent news on NovaBridge Biosciences
See all newsBrief: Visara Secures Exclusive Option For Potential Acquisition Of Yol104-2 For Ocular Surface Squamous Neoplasia
Brief: Visara Expands Ophthalmology Pipeline With Exclusive License For Investigational Nerve Growth Factor Therapy For Neurotrophic Keratitis
Brief: Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Brief: Novabridge Biosciences Announces Expanded Givastomig Safety And Efficacy Data
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview